胺在紧急情况下快速治疗急性自杀念头是否有效? 从试点随机对照试验中学到的教训
Maryam Barzkar1, Kaveh Alavi1, Kazem Malakouti2
1Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
BMC research notes
|February 12, 2025
概括
这项研究发现,虽然胺和米达佐拉姆都减少了患者的自杀念头,但两种药物都没有显示出统计学上显著的疗效差异. 需要进一步的研究来确认胺.
科学领域:
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
背景情况:
- 严重的自杀念头需要快速有效的治疗干预措施.
- 胺已经显示出潜在的抗抑郁作用,但其对急性自杀念头的有效性需要进一步研究.
- 米达佐拉姆通常用于镇静,但其在治疗急性自杀念头方面的作用不太清楚.
研究的目的:
- 为了比较单次胺注射与米达佐拉姆在迅速减少严重自杀念头方面的有效性.
- 评估胺作为治疗急性自杀念头的安全性和有效性.
主要方法:
- 进行了一项双盲随机对照试验,其中36名住院患者经历了急性严重的自杀念头.
- 参与者接受了胺 (0.5毫克/千克) 或米达佐兰 (0.02毫克/千克) 静脉注射.
- 在基线,干预后12小时和24小时,使用贝克自杀想法量表 (BSSI) 和自杀视觉模拟量表 (S-VAS) 评估了自杀倾向.
主要成果:
- 胺和米达佐拉姆组的BSSI和S-VAS得分从基线显著降低到治疗后12和24小时.
- 米达佐拉姆组的基线BSSI得分较高,边缘性人格障碍的患病率更高.
- 在12或24小时内,胺酸和米达佐拉姆组之间没有观察到BSSI或S-VAS得分的统计学上显著差异.
结论:
- 单次输注胺并没有在这个患者群体中快速减少严重的自杀念头方面比米达佐拉姆具有统计学上的显著优势.
- 这两种治疗都导致了显著的症状改善,这表明对急性自杀念头管理的潜在益处.
- 需要对更大样本和更长的随访期进行进一步的研究,以阐明胺在治疗急性自杀念头中的作用.
相关概念视频
01:30Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
01:19Depolarizing Blockers: Pharmocokinetics
305
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
305